RecruitingNot ApplicableNCT06202820

CV CARE: CardioVascular Care in PC Patients

CV CARE: CardioVascular Care of Androgen Related Effects in Prostate Cancer Patients


Sponsor

Dana-Farber Cancer Institute

Enrollment

180 participants

Start Date

Jan 18, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This research is being done to test a program to assess and manage reversible cardiovascular (CV) risk factors in participants with prostate cancer starting androgen deprivation therapy (ADT), with the goal of integrating a standardized method into Dana-Farber Cancer Institute clinics for all such participants. The name of the intervention used in this research study is: CV Care (cardiovascular risk assessment and management program)


Eligibility

Sex: MALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This program (CV CARE) monitors and manages heart health in men with prostate cancer who are starting a long-term hormone therapy called androgen deprivation therapy (ADT), which can raise the risk of heart problems. **You may be eligible if...** - You have prostate cancer at any stage and your doctor recommends at least 24 weeks of ADT (hormone therapy) - You have started ADT but not more than 12 weeks ago - You are willing to attend two heart health check-up visits at weeks 12 and 24 after starting ADT - You are willing to have blood tests and blood pressure checks - You are 18 or older **You may NOT be eligible if...** - You have had a heart attack, new heart failure, or stroke in the last 24 weeks - You have been on ADT for more than 12 weeks already - You are also receiving chemotherapy or radioligand therapy (such as lutetium PSMA) - You are currently enrolled in a therapeutic clinical trial Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALCV Care Program

Comprised of two, in-clinic, counseling sessions with oncology nurse practitioner or physician assistant for education on cardiovascular disease (CVD) and cardiovascular risk factors as well as recommendations for management.


Locations(2)

Brigham and Women's Hospital

Boston, Massachusetts, United States

Dana-Farber Cancer Institute

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06202820


Related Trials